Previous studies demonstrated that a fusion transcript named SLC45A3-ELK4 was formed with exon 1 of SLC45A3 and the last 4 exons of ELK4 [5, 6], which acted as oncogenes in prostate tumor cells without chromosomal changes [7]. The gene discussed is ELK4; the disease is prostate neoplasm.